Article | February 23, 2023

Challenges Facing Aseptic Manufacturing In The Cell And Gene Therapy Market

Source: AST

By Josh Russell

IPC-filling

In the biopharmaceutical world, cell and gene therapies are continuing to gain significant traction. While this technology continues to grow, a number of challenges will inevitably follow. Explore four considerations for aseptic fill/finish challenges in biopharma.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

AST